Managing Director at Cormorant Asset Management
View Live Interactive Profile →Raymond Kelleher is a Managing Director at Cormorant Asset Management. SEC ownership filings under the name Kelleher Raymond J. report him as a director of BridgeBio Oncology Therapeutics, Inc. (Nasdaq: BBOT); his Form 4 for the period ended 16 June 2026 records isDirector as true, and he first filed a Form 3 for that issuer on 11 August 2025. He is also named in Rapport Therapeutics, Inc.'s proxy statement of 23 April 2026, which was not read in this session, so no seat at that issuer is claimed.